UnknownNCT07158450

Evaluation of Wearable Sensor-Based Estimation of Left Ventricular Ejection Fraction (LVEF) - Pilot Study

Sponsor: Skribe Medical

Trial Details

Condition	Cardiotoxicity, Heart Failure
Status	Unknown
Participants	500
Est. Completion	1 Sept 2026
Last Updated	20 May 2026

Primary Outcome

Correlation between wearable-derived and transthoracic echocardiography-derived left ventricular ejection fraction estimates

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Undergoing an echocardiogram irrespective of participation in this study * Willing and able to provide informed consent prior to any study-related activity Exclusion Criteria: * Have a documented allergy to potential tissue contacting system materials * Have any condition that would cause inaccurate TTE measurements

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Pilot Study Opens: Wearable Sensor Technology to Estimate LVEF vs Echocardiography — Implications for Heart Failure Monitoring

A pilot study is evaluating wearable sensor technology to estimate left ventricular ejection fraction compared to standard echocardiography. This innovation could transform continuous cardiac monitoring for heart failure patients and those at risk of cardiotoxicity.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service